✦ LIBER ✦

Study of the combination MIC (mitomycin, ifosfamide and cisplatin) in unresectable or advanced NSCLC as standard treatment. A multicentric study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1087 Study of the combination MIC (mitom

✍ Teixeira, E.; Sotto-Mayor, R.; Azevedo, P.; Preto, P.; Maçanita, J.; Freitas e C 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A randomized study of two vindesine plus

✍ R. Rosell; A. Abad-Esteve; I. Moreno; A. Barnadas; J. Carles; C. Fernandez; N. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

9075 Phase I study of the combination of

✍ Kotsakis, A.; Agelaki, S.; Vardakis, N.; Vamvakas, L.; Kalykaki, A.; Kentepozidi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Combination of cisplatin/S-1 in the trea

✍ Ajani, J.A.; Buyse, M.; Lichinitser, M.; Gorbunova, V.; Bodoky, G.; Douillard, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 502 KB

A Phase I Study of Bortezomib in Combina

✍ Bert H. O'Neil; Laura Raftery; Benjamin F. Calvo; A. Bapsi Chakravarthy; Anastas 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 477 KB

Activity and tolerability of Cisplatin (

✍ D. Galetta; V. Gebbia; S. Romito; F. Ferraù; F. De Marinis; S. Cigolari; S. Adam 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 36 KB